These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1388842)

  • 41. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells.
    Moskophidis D; Lechner F; Pircher H; Zinkernagel RM
    Nature; 1993 Apr; 362(6422):758-61. PubMed ID: 8469287
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunity, immunopathology and vaccines against HIV?
    Zinkernagel RM
    Vaccine; 2002 May; 20(15):1913-7. PubMed ID: 11983244
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Recovery from acute virus infection. Role of cytotoxic T lymphocytes in the elimination of lymphocytic choriomeningitis virus from spleens of mice.
    Lehmann-Grube F; Moskophidis D; Löhler J
    Ann N Y Acad Sci; 1988; 532():238-56. PubMed ID: 3052209
    [No Abstract]   [Full Text] [Related]  

  • 44. In vivo antiviral effect of cytotoxic T lymphocyte clones specific for lymphocytic choriomeningitis virus.
    Cihak J
    Microbiologica; 1986 Jul; 9(3):333-42. PubMed ID: 3489156
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Control of cytotoxic T cell responses].
    Autran B
    Ann Rech Vet; 1992; 23(3):301-4. PubMed ID: 1384418
    [No Abstract]   [Full Text] [Related]  

  • 46. The immune response of the mouse to lymphocytic choriomeningitis virus. V. High numbers of cytolytic T lymphocytes are generated in the spleen during acute infection.
    Moskophidis D; Assmann-Wischer U; Simon MM; Lehmann-Grube F
    Eur J Immunol; 1987 Jul; 17(7):937-42. PubMed ID: 2886344
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Requirements for bone marrow-derived antigen-presenting cells in priming cytotoxic T cell responses to intracellular pathogens.
    Lenz LL; Butz EA; Bevan MJ
    J Exp Med; 2000 Oct; 192(8):1135-42. PubMed ID: 11034603
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [New problems in tolerance induction].
    Hraba T
    Allerg Immunol (Leipz); 1973; 19(2-4):333-41. PubMed ID: 4156163
    [No Abstract]   [Full Text] [Related]  

  • 49. T cell immunity after a viral infection versus T cell tolerance induced by soluble viral peptides.
    Kyburz D; Aichele P; Speiser DE; Hengartner H; Zinkernagel RM; Pircher H
    Eur J Immunol; 1993 Aug; 23(8):1956-62. PubMed ID: 8344359
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Induction of antigen-specific tolerance by cyclosporin A.
    Stitz L
    Eur J Immunol; 1992 Aug; 22(8):1995-2001. PubMed ID: 1322301
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Murine LRBA deficiency causes CTLA-4 deficiency in Tregs without progression to immune dysregulation.
    Burnett DL; Parish IA; Masle-Farquhar E; Brink R; Goodnow CC
    Immunol Cell Biol; 2017 Oct; 95(9):775-788. PubMed ID: 28611475
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunological tolerance to LCMV antigens differently affects control of acute and chronic virus infection in mice.
    Woopen C; Straub T; Schweier O; Aichele U; Düker K; Boehm T; Pircher H
    Eur J Immunol; 2018 Jan; 48(1):120-127. PubMed ID: 28921501
    [TBL] [Abstract][Full Text] [Related]  

  • 53. High frequency of cross-reactive cytotoxic T lymphocytes elicited during the virus-induced polyclonal cytotoxic T lymphocyte response.
    Nahill SR; Welsh RM
    J Exp Med; 1993 Feb; 177(2):317-27. PubMed ID: 8093891
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nonneutralizing antibodies binding to the surface glycoprotein of lymphocytic choriomeningitis virus reduce early virus spread.
    Hangartner L; Zellweger RM; Giobbi M; Weber J; Eschli B; McCoy KD; Harris N; Recher M; Zinkernagel RM; Hengartner H
    J Exp Med; 2006 Aug; 203(8):2033-42. PubMed ID: 16880253
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Crucial role of marginal zone macrophages and marginal zone metallophils in the clearance of lymphocytic choriomeningitis virus infection.
    Seiler P; Aichele P; Odermatt B; Hengartner H; Zinkernagel RM; Schwendener RA
    Eur J Immunol; 1997 Oct; 27(10):2626-33. PubMed ID: 9368619
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A common antiviral cytotoxic T-lymphocyte epitope for diverse major histocompatibility complex haplotypes: implications for vaccination.
    Oldstone MB; Tishon A; Geckeler R; Lewicki H; Whitton JL
    Proc Natl Acad Sci U S A; 1992 Apr; 89(7):2752-5. PubMed ID: 1372990
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immune-mediated viral clearance from the CNS without collateral damage.
    Konradt C; Hunter CA
    J Exp Med; 2015 Jul; 212(8):1141-2. PubMed ID: 26216603
    [No Abstract]   [Full Text] [Related]  

  • 58. A stochastic model of cytotoxic T cell responses.
    Chao DL; Davenport MP; Forrest S; Perelson AS
    J Theor Biol; 2004 May; 228(2):227-40. PubMed ID: 15094017
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Protection against immunopathological consequences of a viral infection by activated but not resting cytotoxic T cells: T cell memory without "memory T cells"?
    Bachmann MF; Kündig TM; Hengartner H; Zinkernagel RM
    Proc Natl Acad Sci U S A; 1997 Jan; 94(2):640-5. PubMed ID: 9012837
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antigen persistence and time of T-cell tolerization determine the efficacy of tolerization protocols for prevention of skin graft rejection.
    Ehl S; Aichele P; Ramseier H; Barchet W; Hombach J; Pircher H; Hengartner H; Zinkernagel RM
    Nat Med; 1998 Sep; 4(9):1015-9. PubMed ID: 9734393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.